Management of Infants at Risk for Group B Streptococcal Disease

Pediatrics. 2019 Aug;144(2):e20191881. doi: 10.1542/peds.2019-1881. Epub 2019 Jul 8.


Group B streptococcal (GBS) infection remains the most common cause of neonatal early-onset sepsis and a significant cause of late-onset sepsis among young infants. Administration of intrapartum antibiotic prophylaxis is the only currently available effective strategy for the prevention of perinatal GBS early-onset disease, and there is no effective approach for the prevention of late-onset disease. The American Academy of Pediatrics joins with the American College of Obstetricians and Gynecologists to reaffirm the use of universal antenatal microbiologic-based testing for the detection of maternal GBS colonization to facilitate appropriate administration of intrapartum antibiotic prophylaxis. The purpose of this clinical report is to provide neonatal clinicians with updated information regarding the epidemiology of GBS disease as well current recommendations for the evaluation of newborn infants at risk for GBS disease and for treatment of those with confirmed GBS infection. This clinical report is endorsed by the American College of Obstetricians and Gynecologists (ACOG), July 2019, and should be construed as ACOG clinical guidance.

Publication types

  • Review

MeSH terms

  • Antibiotic Prophylaxis / methods
  • Antibiotic Prophylaxis / standards*
  • Disease Management*
  • Female
  • Humans
  • Infant, Newborn
  • Practice Guidelines as Topic / standards*
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / drug therapy*
  • Risk Factors
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / prevention & control*